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Abstract 26 
Estrogens are a class of micro-pollutants found in water at low concentrations (in the ng 27 
L
-1
 range), but often sufficient to exert estrogenic effects due to their high estrogenic 28 
potency. Disinfection of waters containing estrogens through oxidative processes has 29 
been shown to lead to the formation of disinfection byproducts, which may also be 30 
estrogenic. The present work investigates the formation of disinfection byproducts of 31 
17β-estradiol (E2) and estrone (E1) in the treatment of water with ozone. Experiments 32 
have been carried out at two different concentrations of the estrogens in ground water 33 
(100 ng L
-1
 and 100 μg L-1) and at varying ozone dosages (0-30 mg L-1). Detection of 34 
the estrogens and their disinfection byproducts in the water samples has been performed 35 
by means of ultra performance liquid chromatography-tandem mass spectrometry 36 
(UPLC-MS/MS) with a triple quadrupole (QqQ) and a quadrupole-time of flight 37 
(QqTOF) instrument. Both E2 and E1 have been found to form two main byproducts, 38 
with molecular mass (MM) 288 and 278 in the case of E2, and 286 and 276 in the case 39 
of E1, following presumably the same reaction pathways. The E2 byproduct with MM 40 
288 has been identified as 10epsilon-17beta-dihydroxy-1,4-estradieno-3-one (DEO), in 41 
agreement with previously published results. The molecular structures and the 42 
formation pathways of the other three newly identified byproducts have been suggested. 43 
These byproducts have been found to be formed at both high and low concentrations of 44 
the estrogens and to be persistent even after application of high ozone dosages. 45 
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1. Introduction 51 
 Ozone can be used in the drinking water process, since it is a powerful oxidant and 52 
disinfectant. However, it can form disinfection byproducts through oxidation with 53 
inorganic and organic compounds (Richardson, 2003).  54 
The presence of some ozonation disinfection byproducts (DBPs), like bromate, 55 
trihalomethanes (THMs) and haloacetic acids (HAAs), is regulated in drinking water to 56 
control and minimize human exposure to these hazardous compounds (USEPA; 57 
European-Communities, 1998). However, there are potentially many more ozonation 58 
DBPs, and until 2003 only less than 50% of the assimilable organic carbon (AOC) 59 
formed during ozonation of water has been characterized (Richardson, 2003).  60 
Compounds such as 17β-estradiol (E2) and estrone (E1), which have endocrine 61 
disrupting properties, are often found in surface water (Kuster et al., 2008; Yoon et al., 62 
2010). If present in the water used as source for abstraction of drinking water these 63 
micro-pollutants can react with ozone forming disinfection byproducts that can pose a 64 
potential risk to the population served with this water. 65 
Sewage treatment effluents are one of the main sources of estrogens in the aquatic 66 
environment. The extent of their degradation during sewage treatment and their 67 
subsequent load into the receiving natural waters is variable, depending on the type of 68 
treatment applied, the hydraulic residence time, the sludge retention time, and other 69 
operational factors (Auriol, 2006; Cargouet et al., 2004; Esperanza, 2007). Furthermore, 70 
since estrogens are female sex hormones naturally produced by vertebrates, non-point 71 
sources, especially in rural areas with intense farming activities, may also be relevant 72 
(Ying et al., 2009). 73 
Of the various natural and synthetic free estrogens E1 and E2 are the most 74 
frequently detected. Their mean/median effluent concentrations in wastewater are 75 
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situated in the range of 20–55 ng L-1 for E1 and 9–20 ng L-1 for E2 (D'Ascenzo et al., 76 
2003). Meanwhile, in surface water the concentrations reported for these two estrogens 77 
in the last years have ranged between 0.7 and 143 ng L
-1
 for E1 (Rodriquez-Mozaz et 78 
al., 2004a, b; Ying et al., 2009) and between 1.4 and 34 ng L
-1
 for E2 (Chen et al., 2007; 79 
Ying et al., 2009). 80 
After entering into the drinking water treatment process E1 and E2, alike other 81 
estrogens and endocrine disrupting compounds (EDCs), are usually gradually and 82 
efficiently, although not necessarily completely, removed (Chang, 2009; Chen et al., 83 
2007). Thus, E2 and E1 have been detected, for instance, in finished drinking water 84 
from Brazil at concentrations up to 6.8 ng L
-1
 and 0.1 ng L
-1
, respectively (Gerolin, 85 
2008, Lopes et al., 2010; Sodre et al., 2010). However, in general, the treatments 86 
applied in drinking water treatment plants (DWTPs) are successful at removing 87 
estrogens, i.e., at eliminating the parent compounds (although this does not necessarily 88 
imply full elimination by e.g. mineralization), and oxidation by ozone and chlorine are 89 
among the most effective and extensively used processes (Benotti et al., 2009b). Other 90 
oxidants, apart from ozone and chlorine (Alum et al., 2004; Bila et al., 2007; Broséus et 91 
al., 2009; Deborde et al., 2005; Hashimoto et al., 2006; Kim et al., 2004; Lin et al., 92 
2009; Maniero et al., 2008; Westerhoff et al., 2005), that have been studied for the 93 
removal of estrogens (parent compound) from water have been chlorine dioxide (Huber 94 
et al., 2005), photolysis (Mazellier et al., 2008), photo-Fenton (Yaping and Jiangyong, 95 
2008; Zhao et al., 2008), titanium dioxide photocatalysis (TiO2/UV) (Benotti et al., 96 
2009a; Ohko et al., 2002; Zhang et al., 2007), ferrate (Lin et al., 2009), electrochemical 97 
degradation (Murugananthan et al., 2007) and sonolysis (Suri et al., 2007). In 98 
comparison with most of these oxidants, ozone presents the advantage of having high 99 
rate constants (Huber et al., 2005) and being a powerful disinfectant. 100 
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Typical doses of ozone (< 2 mg L
-1
) applied during treatment of water containing E1 101 
and E2 have reached 96 to 99% removal of the parent compound (Alum et al., 2004; 102 
Bila et al., 2007; Broséus et al., 2009; Kim et al., 2004; Maniero et al., 2008;Westerhoff 103 
et al., 2005). However, some works have reported the formation of byproducts after the 104 
removal of E1 and E2 (Pereira et al., 2011). In this context, the objective of this work 105 
was to investigate the formation of E1 and E2 byproducts during ozonation, to try to 106 
identify them, and to estimate the dose of ozone necessary for the complete removal of 107 
these byproducts.  108 
2.  Materials and Methods  109 
2.1. Reagents and solutions  110 
HPLC-grade acetone, methanol and water were supplied by Merck (Darmstadt, 111 
Germany). Pure standards of 17β-estradiol (E2), estrone (E1), 6α-hydroxyestradiol, 4-112 
hydroxyestradiol, and 2-hydroxyestradiol were purchased from Sigma Aldrich 113 
(Steinheim, Germany). Individual stock solutions of the analytes were prepared at 100 114 
mg L
-1
 by dissolving 10 mg of each compound in 100 mL of methanol. Estrogens in 115 
methanol solutions stored in the dark at 4°C are stable for at least 6 months. The 116 
solutions at 100 μg L-1 and 100 ng L-1 were freshly prepared before every batch of 117 
experiments by appropriate dilution of the individual stock solutions in ground water. 118 
Ground water from the University of São Paulo (São Carlos Campus, Brazil) 119 
collected before chlorination was used to carry out the assays. After collection it was 120 
stored at 4 ºC until use. This water source was chosen because of the similarity of its 121 
characteristics with those of drinking water, with the required quality in terms of 122 
average turbidity (0.4 ± 0.2 NTU) and average color (1.0 ± 1.5 Pt-Co units).  123 
2.2. Ozonation experiments 124 
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The ozonation experiments were carried out in a pilot scale experimental unit 125 
(Supplementary Information - 1). The ozonation reactor had a total height of 3.5 m, a 126 
working height of 3.0 m, an external diameter of 110 mm and a volume of 28.5 L. The 127 
ozone generator (EAGLESAT®, Brazil) was a corona discharge type and had an 128 
oxygen generation unit (PSA method - Pressure Swing Adsorption) and a compressor to 129 
generate ozone. The production of ozone in the gas phase was measured with an ozone 130 
analyzer (IN USA, ASX-Mod H1) coupled to a rotameter. The ozone was applied to the 131 
base of the reactor using a porous diffuser and the off-gas was captured in a flask 132 
containing potassium iodide solution at 2% (w/w). The total ozone consumed was 133 
calculated according to equation 1. 134 
                                        CO = AO - OF - RO                                                    (1) 135 
Where, CO is the consumed ozone (mg L
-1
), AO is the applied ozone (mg L
-1
), OF 136 
is the ozone in the off-gas (mg L
-1
), and RO is the residual ozone in the liquid phase 137 
(mg L
-1
). Therefore, the concentration of ozone expressed in the present work is the 138 
ozone consumed during the reaction time.  139 
Experiments were performed at two different initial concentrations of E2 and E1 140 
(100 µg L
-1
 and 100 ng L
-1
), in separated batches for each estrogen and one treatment 141 
was done for each dose of ozone (batch experiments). The experiments at 100 µg L
-1
 142 
were conducted first. The objective in this case was to identify the main byproducts 143 
formed during ozonation. Then the experiments at 100 ng L
-1
 were performed in order 144 
to track and confirm the presence of the previously identified byproducts but at 145 
concentrations closer to those found in real samples (surface water). In all cases the 146 
dose of ozone applied ranged from 0.4 to 28 mg L
-1
, the temperature was set at 19 ± 2ºC 147 
and the natural pH of the ground water at the beginning of the treatments was 7.0 ± 0.3. 148 
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After the ozone application, aliquots of 200 mL were withdrawn from the reactor 149 
and the residual ozone in the water samples was measured by indigo colorimetric 150 
method 4500-O3 B (APHA, 1998) immediately after the assays.  151 
2.3. Analysis  152 
2.3.1 Sample preparation  153 
Samples (200 mL) were preconcentrated by solid phase extraction (SPE) with C18 154 
cartridges (Accubond, 500 mg) from Agilent Technologies (Santa Clara, CA, USA) 155 
following a procedure adapted from Ternes et al. (1999). After sample loading the 156 
cartridges were rinsed with 10 mL of HPLC water and eluted with 4 mL of acetone. 157 
Main differences with respect to the method described by Ternes et al. (1999) refer to 158 
the sample volume (200 mL vs 1 L) and the performance of a washing step of the 159 
cartridge prior to elution. The extracts obtained were then blown down to dryness under 160 
nitrogen, reconstituted with methanol to a final volume of 0.5 mL, and stored in the 161 
dark at 4C for subsequent LC–MS/MS analysis. Under these conditions both E1 and 162 
E2 are stable for at least 60 days (recovery percentage ± relative standard deviation 163 
equal to 96 ± 1% and 102 ± 5% for E1 and E2, respectively). 164 
2.3.2. Identification of byproducts by UPLC-QqToF-MS/MS  165 
Identification of E1 and E2 ozonation byproducts in the water samples extracts 166 
coming from the experiments performed at 100 μg L-1 (see section 2.2) was carried out 167 
by UPLC-QqTOF-MS/MS on a Waters Acquity UPLC system (Waters Corp., Mildford, 168 
MA) equipped with a binary solvent delivery system and an autosampler coupled to a 169 
Waters QqToF-Micro MS/MS detector. Chromatographic separation was performed on 170 
a Hibar HR Purospher STAR RP-18 column (30 x 2.1 mm, 2 µm particle size) from 171 
Merck (Darmstadt, Germany). The column temperature was set to 35 ºC and the 172 
samples compartment temperature was kept to 10 ºC. The injection volume was 5 µL 173 
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and the column flow rate 0.4 mL min
-1
. The mobile phase consisted of A (acetonitrile) 174 
and B (water). The gradient started with 10% A, composition that was kept constant for 175 
2 min, then linearly increased to 25% A over 2 minutes, kept constant for 1 min, 176 
linearly increased to 50% A over 1 min, kept constant for 2 min, raised to 100% A in 2 177 
min, maintain constant for 1 min, and decreased to 10% A within 1 minute. Total run 178 
time, including reequilibration of the column to the initial conditions, was 12 minutes.   179 
Detection was performed with an electrospray (ESI) interface in the negative 180 
ionization (NI) and with the capillary voltage set to 2800 V and cone voltages varying 181 
between 10 and 50 V. The nebulization gas (nitrogen) was set to 500 L h
-1
 at a 182 
temperature of 450 
o
C; the cone gas (nitrogen) was set to 30 L h
-1
, and the source 183 
temperature to 150 
 o
C. For MS experiments, the instrument was operated in a wide pass 184 
quadrupole mode with the TOF data being collected between m/z 50 and 600 and low 185 
collision energy (CE) of 4 eV. The product ion MS/MS experiments were performed at 186 
variable CE (10–50 eV). All analyses were performed using an independent reference 187 
spray (lockSpray) to ensure accuracy and reproducibility. Val-Tyr-Val was used as lock 188 
mass (m/z 380.2029) for internal mass calibration. 189 
Instrument control, data acquisition, and evaluation were done by means of 190 
MassLynx V4.1 software (Waters Corp.). This software (Waters Corp.) calculates all 191 
possible elemental compositions for a given accurate mass and is thus a potent tool for 192 
hypothesizing possible structures of unknown compounds. Final identification can then 193 
be performed based on the accurate mass measurements of the parent ions and 194 
fragments obtained in MS/MS experiments. 195 
2.3.3. Analysis of byproducts by UPLC-QqQ-MS/MS 196 
Analysis of the previously identified byproducts in the water extracts coming from 197 
the experiments performed at low initial concentration of estrogens (100 ng L
-1
) was 198 
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carried out by UPLC-QqQ-MS/MS on a Waters Acquity UPLC system coupled to a 199 
Waters TQD MS/MS detector. Chromatographic conditions were the same as described 200 
above for UPLC-QqToF-MS/MS analysis except for the injection volume which was set 201 
to 8 µL to increase sensitivity. MS/MS detection was performed in the selected reaction 202 
monitoring (SRM) mode using ESI in the NI mode and basically the same MS/MS 203 
conditions described above: capillary voltage, 2800 V; nebulization gas flow rate, 650 L 204 
h
-1
; desolvation temperature, 450 ºC; cone gas flow rate, 30 L h
-1
; source temperature, 205 
150 ºC. SRM transitions and the cone and collision voltages selected for the monitoring 206 
of the previously identified byproducts is showed in Supplementary Information - 2. 207 
Optimization of these conditions was performed with the samples coming from the high 208 
concentration experiments conducted before. Instrument control and data acquisition 209 
and evaluation were done with the software MassLynx V4.1. 210 
3. Results and Discussion 211 
Figure 1 shows the disappearance of E1 and E2 during ozonation in the experiments 212 
conducted with initial concentration of 100 μg L-1 of the estrogens in water. As it can be 213 
seen, both estrogens vanish rapidly, although the reaction of ozone with E1 is slightly 214 
faster than with E2. Parallel to the disappearance of the estrogens, a number of other 215 
new peaks appear in the UPLC-QqTOF-MS chromatograms obtained throughout the 216 
experiments.  The m/z ratios and the corresponding retention times of the major peaks 217 
identified in the degradation of E1 and E2 are depicted in Figure 2. The main 218 
byproducts of E1 (with nominal m/z ratios 285, 275, 301, and 305) are similar to those 219 
of E2 (with nominal m/z ratios 287, 277, 303, and 307) with a difference of two mass 220 
units between them, which coincides with the difference of two mass units also in the 221 
molecular mass (MM) of the parent compounds (270.36608 g/mol for E1 and 222 
272.38196 g/mol for E2). Since this difference is due to the presence of a ketone group 223 
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in position 17 of the molecular structure of E1 and a hydroxyl group in the same 224 
position of the E2 molecule, it is clear that ozone attacks the aromatic moiety, where the 225 
high electronic densities on the carbons located in the ortho and para positions favor the 226 
process (Figure 1).  227 
(Figure 1) 228 
In both cases the most abundant and persistent byproducts are the ones with lower 229 
m/z ratios: 285 and 275 for E1, and 287 and 277 for E2. The other byproducts, with m/z 230 
301 and 305 in the case of E1, and m/z 303 and 307 in the case of E2, are formed in 231 
much less quantity and are therefore not considered further for discussion. 232 
(Figure 2) 233 
Figure 2A shows that the E1 byproduct with m/z 285 is fairly stable until an ozone 234 
dosage of 12 mg O3 L
-1
, decreasing thereafter but not disappearing. Meanwhile the 235 
compound with m/z 275 and retention time 4.27 min rises until the ozone dosage 236 
reaches 16.7 mg O3 L
-1
 and its concentration keeps fairly constant afterwards. As it is 237 
shown in Figure 2B, the E2 byproducts show a rather similar behavior, except for the 238 
fact that the byproduct with m/z 287 starts to decrease at a lower ozone dosage, 4.0 mg 239 
O3 L
-1
, than the E1 byproduct with m/z 285. 240 
The elemental compositions proposed by the Masslynx software for the 241 
experimental accurate masses measured by the QqTOF-MS/MS detector, after applying 242 
basic organic chemical rules to eliminate nonfeasible formulae and possible degradation 243 
scenarios for the parent compounds, were C18H23O3 for m/z 287 and C16H21O4 for m/z 244 
277. However, considering the structure of E2 and that the most probable attack occurs 245 
at the aromatic ring (high electronic densities) there are more than one possible structure 246 
for m/z 287 or, in other words, with mass 288. The structures proposed so far in the 247 
scientific literature for E2 disinfection byproducts with molecular mass 288 have been: 248 
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2-hydroxyestradiol (2OH-E2), identified by both Bila et al. (2007) and Maniero et al. 249 
(2008), monohydroxylated E2 (Irmak et al., 2005), 10e-17b-dihydroxy-1,4-estradieno-250 
3-one (DEO) (Bila et al., 2007) and testosterone (Bila et al., 2007; Maniero et al., 2008) 251 
in ozonation experiments. In experiments performed with other types of oxidation 252 
processes such as, photo-Fenton, photolysis, or TiO2 photocatalysis the compounds 253 
previously identified were: 6-hydroxyestradiol (6OH-E2) (Mazellier et al., 2008; Zhao 254 
et al., 2008), again 2OH-E2 , testosterone (Ohko et al., 2002; Zhao et al., 2008) and 255 
DEO (Mai et al., 2008; Zhao et al., 2008). The E2 byproduct with mass 278 (m/z 277) 256 
has never been reported in the literature. 257 
Trying to elucidate the structure of the byproduct with mass 288 the standards that 258 
were available (2OH-E2, 4OH-E2, and 6OH-E2) were acquired and analyzed. However, 259 
as it can be seen in Figure 3 the retention times of the standards 2OH-E2 (5.69 min) and 260 
4OH-E2 (5.79 min) were very different from the retention time of the E2 byproducts 261 
with MM 288 (4.05 and 4.36 min) detected in our ozonation experiments (16.7 mg O3 262 
L
-1
). On the contrary the retention time of the standard 6OH-E2 (3.99 min) was quite 263 
similar, but when the molecules were fragmented their fragments were totally different 264 
from each other, indicating that 6OH-E2 is not the targeted byproduct. The standard of 265 
estriol (E3), which also has a MM of 288, was tested as well, but the LC-MS data did 266 
not fit either. Apart from these there are other structure possibilities for MM 288, but 267 
these structures do not have their corresponding counterparts for MM 286 when the 268 
same degradation mechanism is applied to the E1 molecule. The compound testosterone 269 
was also disregarded because its formulae (C19H28O2) contains only two oxygens 270 
(instead of three). Thus the byproduct with MM 288 is expected to be the compound 271 
named DEO. DEO was suggested by Ohko et al. in 2002 as byproduct in the mechanism 272 
of degradation of E2 by TiO2 photocatalysis (Ohko et al., 2002) and further confirmed 273 
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by Mai et al. in 2008 in similar oxidative processes by LC-MS/MS analysis (Mai et al., 274 
2008). Furthermore, the fragments observed by Mai et al. (2008) were similar to those 275 
found in the present study.  276 
(Figure 3) 277 
The fragmentation of the E2 and E1 byproducts with m/z 287 and m/z 285, 278 
respectively, is shown in Figure 4. The part marked in the square is virtually identical, 279 
i.e., presents the same fragment ions, in both compounds, whereas the circled part 280 
shows a similar fragmentation pattern but with a difference of two mass units. Based on 281 
these spectra and on previously published works (Bila et al., 2007; Mai et al., 2008; 282 
Ohko et al., 2002;  Zhao et al., 2008) the E2 byproduct with m/z 287 is believed to be 283 
DEO, and the main E1 byproduct with m/z 285 is believed to correspond to a similar 284 
compound but with a ketone group instead of a hydroxyl group in position 17, i.e. to 10-285 
hydroxy-1,4-estradieno-3,17-dione (HEDO). 286 
(Figure 4) 287 
The formation pathway of DEO from E2 has already been suggested by Mai et al. 288 
(2008) and according to it the formation pathway of the above suggested E1 byproduct 289 
would be the same.  290 
It may be worth mentioning that the pH of the samples (measured at the beginning 
291 
and at the end of the experiments) decreased as the formation of the byproducts 
292 
increased (following the loss of H
+
 and the addition of OH in the molecule) and vice 
293 
versa, as it is shown in Supplementary Information - 3 for the byproduct with m/z 285. 
294 
For the E2 and E1 byproducts with m/z 277 and m/z 275, respectively, the pathway 295 
of degradation based on the mechanism of phenol ozonolysis (Komissarov et al., 2006) 296 
is suggested. This pathway is illustrated in Figure 5 for E2. The pathway for E1 would 297 
be similar but maintaining the ketone group that is present in position 17 in the original 298 
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E1 structure. Figure 6 shows the product ion mass spectra and the purported 299 
fragmentation of the byproducts with m/z 277 and m/z 275 that support the proposed 300 
structures. 301 
The finding of these byproducts, not reported previously by other authors, could be 302 
due to the use of different equipments and/or experimental conditions. In the works 303 
performed by Bila et al. (2007) and Maniero et al. (2008) the ozone doses and the initial 304 
concentration of E2 were comparable to those used in the present study but the 305 
identification of byproducts was carried out by GC/MS. In the work conducted by 306 
Irmak et al. (2005) the detection of byproducts was performed by LC-MS/MS but the 307 
conditions of the experiment were very different from ours with higher initial estrogen 308 
concentrations and unclear doses of ozone consumed. Another possible difference could 309 
be the reactive form triggering the process in each work, which in our study, conducted 310 
at pH around 7, would be basically molecular ozone and in other studies OH radicals. 311 
(Figure 5) 312 
(Figure 6) 313 
The ozonation experiments carried out at lower initial concentrations of the 314 
estrogens (100 ng L
-1
) were conducted with the double objective of, first, confirming the 315 
formation of the previously identified main byproducts at concentrations in water closer 316 
to those found in the environment and, secondly, determining the ozone dosage that 317 
would have to be applied to remove them. Figure 7 shows the evolution of the targeted 318 
byproducts during the ozonation experiments. As it can be seen, some byproducts were 319 
formed and reached their maximum concentration at an ozone dosage of approximately 320 
0.5 mg O3 L
-1
, decreasing afterwards. Comparatively, the E2 byproducts, that persisted 321 
until an ozone dosage of 16 mg O3 L
-1
, were more recalcitrant than the E1 byproducts, 322 
that disappeared at a lower ozone dosage of 10 mg O3 L
-1
. 323 
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The E2 and E1 byproducts with m/z 287 and m/z 285, respectively, had the same 324 
behavior, being both completely removed (below equipment detection limits) after an 325 
ozone dosage of 4 mg O3 L
-1 
(Figure 7). The E1 byproduct with m/z 275 and the E2 326 
byproduct with m/z 277 remained longer in the solution, until the ozone dosage reached 327 
10 and 16 mg O3 L
-1
, respectively. 328 
(Figure 7) 329 
Several authors that have investigated the estrogenicity of disinfected waters have 330 
observed estrogenic activity after water ozonation (Alum et al., 2004; Huber et al., 331 
2004; Kim et al., 2004; Maniero et al., 2008), indicating the occurrence of byproducts 332 
and that these byproducts are also biologically active even after application of high 333 
ozone dosages. An increase in the concentration of ozone from 0.5 to 10 mg L
-1
 has 334 
been shown to reduce the estrogenicity of the original water by a factor of 200 to 1000 335 
(Huber et al., 2004). This residual estrogenicity, although low, may still be relevant if 336 
we consider that water is just one of many possible routes of exposure to estrogenic 337 
compounds.  338 
4.  Conclusions 339 
E2 and E1 have shown to be efficiently removed from water through ozonation, but 340 
to form each of them two major byproducts. These byproducts with MM 288 and 278, 341 
and 286 and 276, respectively, have been tentatively identified (the last three for the 342 
first time) by means of UPLC-QqTOF-MS/MS. E2 and E1 are believed to follow the 343 
same degradation pathway since their corresponding byproducts, alike them, differ in 344 
two mass units. The total elimination of these byproducts occurred only with high ozone 345 
dosages (10 mg and 16 mg O3 L
-1
 for the E1 and E2 byproducts, respectively).  346 
The ozonation byproducts can pose a risk not only to drinking water consumers but 347 
also to aquatic organisms that can become exposed to them through reclaimed water 348 
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having been subjected to ozonation or when ozone treated wastewater is released into 349 
the environment. Thus, for a proper evaluation of the risk associated to the use of 350 
ozonized water, the ecotoxicity and estrogenicity of the byproducts should be evaluated.  351 
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Abstract 26 
Estrogens are a class of micro-pollutants found in water at low concentrations (in the ng 27 
L
-1
 range), but often sufficient to exert estrogenic effects due to their high estrogenic 28 
potency. Disinfection of waters containing estrogens through oxidative processes has 29 
been shown to lead to the formation of disinfection byproducts, which may also be 30 
estrogenic. The present work investigates the formation of disinfection byproducts of 31 
17β-estradiol (E2) and estrone (E1) in the treatment of water with ozone. Experiments 32 
have been carried out at two different concentrations of the estrogens in ground water 33 
(100 ng L
-1
 and 100 μg L-1) and at varying ozone dosages (0-30 mg L-1). Detection of 34 
the estrogens and their disinfection byproducts in the water samples has been performed 35 
by means of ultra performance liquid chromatography-tandem mass spectrometry 36 
(UPLC-MS/MS) with a triple quadrupole (QqQ) and a quadrupole-time of flight 37 
(QqTOF) instrument. Both E2 and E1 have been found to form two main byproducts, 38 
with molecular mass (MM) 288 and 278 in the case of E2, and 286 and 276 in the case 39 
of E1, following presumably the same reaction pathways. The E2 byproduct with MM 40 
288 has been identified as 10epsilon-17beta-dihydroxy-1,4-estradieno-3-one (DEO), in 41 
agreement with previously published results. The molecular structures and the 42 
formation pathways of the other three newly identified byproducts have been suggested. 43 
These byproducts have been found to be formed at both high and low concentrations of 44 
the estrogens and to be persistent even after application of high ozone dosages. 45 
 46 
Keywords: estrogen; drinking water; oxidation process; disinfection byproduct. 47 
 48 
 49 
 50 
 3 
1. Introduction 51 
 Ozone can be used in the drinking water process, since it is a powerful oxidant and 52 
disinfectant. However, it can form disinfection byproducts through oxidation with 53 
inorganic and organic compounds (Richardson, 2003).  54 
The presence of some ozonation disinfection byproducts (DBPs), like bromate, 55 
trihalomethanes (THMs) and haloacetic acids (HAAs), is regulated in drinking water to 56 
control and minimize human exposure to these hazardous compounds (USEPA; 57 
European-Communities, 1998). However, there are potentially many more ozonation 58 
DBPs, and until 2003 only less than 50% of the assimilable organic carbon (AOC) 59 
formed during ozonation of water has been characterized (Richardson, 2003).  60 
Compounds such as 17β-estradiol (E2) and estrone (E1), which have endocrine 61 
disrupting properties, are often found in surface water (Kuster et al., 2008; Yoon et al., 62 
2010). If present in the water used as source for abstraction of drinking water these 63 
micro-pollutants can react with ozone forming disinfection byproducts that can pose a 64 
potential risk to the population served with this water. 65 
Sewage treatment effluents are one of the main sources of estrogens in the aquatic 66 
environment. The extent of their degradation during sewage treatment and their 67 
subsequent load into the receiving natural waters is variable, depending on the type of 68 
treatment applied, the hydraulic residence time, the sludge retention time, and other 69 
operational factors (Auriol, 2006; Cargouet et al., 2004; Esperanza, 2007). Furthermore, 70 
since estrogens are female sex hormones naturally produced by vertebrates, non-point 71 
sources, especially in rural areas with intense farming activities, may also be relevant 72 
(Ying et al., 2009). 73 
Of the various natural and synthetic free estrogens E1 and E2 are the most 74 
frequently detected. Their mean/median effluent concentrations in wastewater are 75 
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situated in the range of 20–55 ng L-1 for E1 and 9–20 ng L-1 for E2 (D'Ascenzo et al., 76 
2003). Meanwhile, in surface water the concentrations reported for these two estrogens 77 
in the last years have ranged between 0.7 and 143 ng L
-1
 for E1 (Rodriquez-Mozaz et 78 
al., 2004a, b; Ying et al., 2009) and between 1.4 and 34 ng L
-1
 for E2 (Chen et al., 2007; 79 
Ying et al., 2009). 80 
After entering into the drinking water treatment process E1 and E2, alike other 81 
estrogens and endocrine disrupting compounds (EDCs), are usually gradually and 82 
efficiently, although not necessarily completely, removed (Chang, 2009; Chen et al., 83 
2007). Thus, E2 and E1 have been detected, for instance, in finished drinking water 84 
from Brazil at concentrations up to 6.8 ng L
-1
 and 0.1 ng L
-1
, respectively (Gerolin, 85 
2008, Lopes et al., 2010; Sodre et al., 2010). However, in general, the treatments 86 
applied in drinking water treatment plants (DWTPs) are successful at removing 87 
estrogens, i.e., at eliminating the parent compounds (although this does not necessarily 88 
imply full elimination by e.g. mineralization), and oxidation by ozone and chlorine are 89 
among the most effective and extensively used processes (Benotti et al., 2009b). Other 90 
oxidants, apart from ozone and chlorine (Alum et al., 2004; Bila et al., 2007; Broséus et 91 
al., 2009; Deborde et al., 2005; Hashimoto et al., 2006; Kim et al., 2004; Lin et al., 92 
2009; Maniero et al., 2008; Westerhoff et al., 2005), that have been studied for the 93 
removal of estrogens (parent compound) from water have been chlorine dioxide (Huber 94 
et al., 2005), photolysis (Mazellier et al., 2008), photo-Fenton (Yaping and Jiangyong, 95 
2008; Zhao et al., 2008), titanium dioxide photocatalysis (TiO2/UV) (Benotti et al., 96 
2009a; Ohko et al., 2002; Zhang et al., 2007), ferrate (Lin et al., 2009), electrochemical 97 
degradation (Murugananthan et al., 2007) and sonolysis (Suri et al., 2007). In 98 
comparison with most of these oxidants, ozone presents the advantage of having high 99 
rate constants (Huber et al., 2005) and being a powerful disinfectant. 100 
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Typical doses of ozone (< 2 mg L
-1
) applied during treatment of water containing E1 101 
and E2 have reached 96 to 99% removal of the parent compound (Alum et al., 2004; 102 
Bila et al., 2007; Broséus et al., 2009; Kim et al., 2004; Maniero et al., 2008;Westerhoff 103 
et al., 2005). However, some works have reported the formation of byproducts after the 104 
removal of E1 and E2 (Pereira et al., 2011). In this context, the objective of this work 105 
was to investigate the formation of E1 and E2 byproducts during ozonation, to try to 106 
identify them, and to estimate the dose of ozone necessary for the complete removal of 107 
these byproducts.  108 
2.  Materials and Methods  109 
2.1. Reagents and solutions  110 
HPLC-grade acetone, methanol and water were supplied by Merck (Darmstadt, 111 
Germany). Pure standards of 17β-estradiol (E2), estrone (E1), 6α-hydroxyestradiol, 4-112 
hydroxyestradiol, and 2-hydroxyestradiol were purchased from Sigma Aldrich 113 
(Steinheim, Germany). Individual stock solutions of the analytes were prepared at 100 114 
mg L
-1
 by dissolving 10 mg of each compound in 100 mL of methanol. Estrogens in 115 
methanol solutions stored in the dark at 4°C are stable for at least 6 months. The 116 
solutions at 100 μg L-1 and 100 ng L-1 were freshly prepared before every batch of 117 
experiments by appropriate dilution of the individual stock solutions in ground water. 118 
Ground water from the University of São Paulo (São Carlos Campus, Brazil) 119 
collected before chlorination was used to carry out the assays. After collection it was 120 
stored at 4 ºC until use. This water source was chosen because of the similarity of its 121 
characteristics with those of drinking water, with the required quality in terms of 122 
average turbidity (0.4 ± 0.2 NTU) and average color (1.0 ± 1.5 Pt-Co units).  123 
2.2. Ozonation experiments 124 
 6 
The ozonation experiments were carried out in a pilot scale experimental unit 125 
(Supplementary Information - 1). The ozonation reactor had a total height of 3.5 m, a 126 
working height of 3.0 m, an external diameter of 110 mm and a volume of 28.5 L. The 127 
ozone generator (EAGLESAT®, Brazil) was a corona discharge type and had an 128 
oxygen generation unit (PSA method - Pressure Swing Adsorption) and a compressor to 129 
generate ozone. The production of ozone in the gas phase was measured with an ozone 130 
analyzer (IN USA, ASX-Mod H1) coupled to a rotameter. The ozone was applied to the 131 
base of the reactor using a porous diffuser and the off-gas was captured in a flask 132 
containing potassium iodide solution at 2% (w/w). The total ozone consumed was 133 
calculated according to equation 1. 134 
                                        CO = AO - OF - RO                                                    (1) 135 
Where, CO is the consumed ozone (mg L
-1
), AO is the applied ozone (mg L
-1
), OF 136 
is the ozone in the off-gas (mg L
-1
), and RO is the residual ozone in the liquid phase 137 
(mg L
-1
). Therefore, the concentration of ozone expressed in the present work is the 138 
ozone consumed during the reaction time.  139 
Experiments were performed at two different initial concentrations of E2 and E1 140 
(100 µg L
-1
 and 100 ng L
-1
), in separated batches for each estrogen and one treatment 141 
was done for each dose of ozone (batch experiments). The experiments at 100 µg L
-1
 142 
were conducted first. The objective in this case was to identify the main byproducts 143 
formed during ozonation. Then the experiments at 100 ng L
-1
 were performed in order 144 
to track and confirm the presence of the previously identified byproducts but at 145 
concentrations closer to those found in real samples (surface water). In all cases the 146 
dose of ozone applied ranged from 0.4 to 28 mg L
-1
, the temperature was set at 19 ± 2ºC 147 
and the natural pH of the ground water at the beginning of the treatments was 7.0 ± 0.3. 148 
 7 
After the ozone application, aliquots of 200 mL were withdrawn from the reactor 149 
and the residual ozone in the water samples was measured by indigo colorimetric 150 
method 4500-O3 B (APHA, 1998) immediately after the assays.  151 
2.3. Analysis  152 
2.3.1 Sample preparation  153 
Samples (200 mL) were preconcentrated by solid phase extraction (SPE) with C18 154 
cartridges (Accubond, 500 mg) from Agilent Technologies (Santa Clara, CA, USA) 155 
following a procedure adapted from Ternes et al. (1999). After sample loading the 156 
cartridges were rinsed with 10 mL of HPLC water and eluted with 4 mL of acetone. 157 
Main differences with respect to the method described by Ternes et al. (1999) refer to 158 
the sample volume (200 mL vs 1 L) and the performance of a washing step of the 159 
cartridge prior to elution. The extracts obtained were then blown down to dryness under 160 
nitrogen, reconstituted with methanol to a final volume of 0.5 mL, and stored in the 161 
dark at 4C for subsequent LC–MS/MS analysis. Under these conditions both E1 and 162 
E2 are stable for at least 60 days (recovery percentage ± relative standard deviation 163 
equal to 96 ± 1% and 102 ± 5% for E1 and E2, respectively). 164 
2.3.2. Identification of byproducts by UPLC-QqToF-MS/MS  165 
Identification of E1 and E2 ozonation byproducts in the water samples extracts 166 
coming from the experiments performed at 100 μg L-1 (see section 2.2) was carried out 167 
by UPLC-QqTOF-MS/MS on a Waters Acquity UPLC system (Waters Corp., Mildford, 168 
MA) equipped with a binary solvent delivery system and an autosampler coupled to a 169 
Waters QqToF-Micro MS/MS detector. Chromatographic separation was performed on 170 
a Hibar HR Purospher STAR RP-18 column (30 x 2.1 mm, 2 µm particle size) from 171 
Merck (Darmstadt, Germany). The column temperature was set to 35 ºC and the 172 
samples compartment temperature was kept to 10 ºC. The injection volume was 5 µL 173 
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and the column flow rate 0.4 mL min
-1
. The mobile phase consisted of A (acetonitrile) 174 
and B (water). The gradient started with 10% A, composition that was kept constant for 175 
2 min, then linearly increased to 25% A over 2 minutes, kept constant for 1 min, 176 
linearly increased to 50% A over 1 min, kept constant for 2 min, raised to 100% A in 2 177 
min, maintain constant for 1 min, and decreased to 10% A within 1 minute. Total run 178 
time, including reequilibration of the column to the initial conditions, was 12 minutes.   179 
Detection was performed with an electrospray (ESI) interface in the negative 180 
ionization (NI) and with the capillary voltage set to 2800 V and cone voltages varying 181 
between 10 and 50 V. The nebulization gas (nitrogen) was set to 500 L h
-1
 at a 182 
temperature of 450 
o
C; the cone gas (nitrogen) was set to 30 L h
-1
, and the source 183 
temperature to 150 
 o
C. For MS experiments, the instrument was operated in a wide pass 184 
quadrupole mode with the TOF data being collected between m/z 50 and 600 and low 185 
collision energy (CE) of 4 eV. The product ion MS/MS experiments were performed at 186 
variable CE (10–50 eV). All analyses were performed using an independent reference 187 
spray (lockSpray) to ensure accuracy and reproducibility. Val-Tyr-Val was used as lock 188 
mass (m/z 380.2029) for internal mass calibration. 189 
Instrument control, data acquisition, and evaluation were done by means of 190 
MassLynx V4.1 software (Waters Corp.). This software (Waters Corp.) calculates all 191 
possible elemental compositions for a given accurate mass and is thus a potent tool for 192 
hypothesizing possible structures of unknown compounds. Final identification can then 193 
be performed based on the accurate mass measurements of the parent ions and 194 
fragments obtained in MS/MS experiments. 195 
2.3.3. Analysis of byproducts by UPLC-QqQ-MS/MS 196 
Analysis of the previously identified byproducts in the water extracts coming from 197 
the experiments performed at low initial concentration of estrogens (100 ng L
-1
) was 198 
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carried out by UPLC-QqQ-MS/MS on a Waters Acquity UPLC system coupled to a 199 
Waters TQD MS/MS detector. Chromatographic conditions were the same as described 200 
above for UPLC-QqToF-MS/MS analysis except for the injection volume which was set 201 
to 8 µL to increase sensitivity. MS/MS detection was performed in the selected reaction 202 
monitoring (SRM) mode using ESI in the NI mode and basically the same MS/MS 203 
conditions described above: capillary voltage, 2800 V; nebulization gas flow rate, 650 L 204 
h
-1
; desolvation temperature, 450 ºC; cone gas flow rate, 30 L h
-1
; source temperature, 205 
150 ºC. SRM transitions and the cone and collision voltages selected for the monitoring 206 
of the previously identified byproducts is showed in Supplementary Information - 2. 207 
Optimization of these conditions was performed with the samples coming from the high 208 
concentration experiments conducted before. Instrument control and data acquisition 209 
and evaluation were done with the software MassLynx V4.1. 210 
3. Results and Discussion 211 
Figure 1 shows the disappearance of E1 and E2 during ozonation in the experiments 212 
conducted with initial concentration of 100 μg L-1 of the estrogens in water. As it can be 213 
seen, both estrogens vanish rapidly, although the reaction of ozone with E1 is slightly 214 
faster than with E2. Parallel to the disappearance of the estrogens, a number of other 215 
new peaks appear in the UPLC-QqTOF-MS chromatograms obtained throughout the 216 
experiments.  The m/z ratios and the corresponding retention times of the major peaks 217 
identified in the degradation of E1 and E2 are depicted in Figure 2. The main 218 
byproducts of E1 (with nominal m/z ratios 285, 275, 301, and 305) are similar to those 219 
of E2 (with nominal m/z ratios 287, 277, 303, and 307) with a difference of two mass 220 
units between them, which coincides with the difference of two mass units also in the 221 
molecular mass (MM) of the parent compounds (270.36608 g/mol for E1 and 222 
272.38196 g/mol for E2). Since this difference is due to the presence of a ketone group 223 
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in position 17 of the molecular structure of E1 and a hydroxyl group in the same 224 
position of the E2 molecule, it is clear that ozone attacks the aromatic moiety, where the 225 
high electronic densities on the carbons located in the ortho and para positions favor the 226 
process (Figure 1).  227 
(Figure 1) 228 
In both cases the most abundant and persistent byproducts are the ones with lower 229 
m/z ratios: 285 and 275 for E1, and 287 and 277 for E2. The other byproducts, with m/z 230 
301 and 305 in the case of E1, and m/z 303 and 307 in the case of E2, are formed in 231 
much less quantity and are therefore not considered further for discussion. 232 
(Figure 2) 233 
Figure 2A shows that the E1 byproduct with m/z 285 is fairly stable until an ozone 234 
dosage of 12 mg O3 L
-1
, decreasing thereafter but not disappearing. Meanwhile the 235 
compound with m/z 275 and retention time 4.27 min rises until the ozone dosage 236 
reaches 16.7 mg O3 L
-1
 and its concentration keeps fairly constant afterwards. As it is 237 
shown in Figure 2B, the E2 byproducts show a rather similar behavior, except for the 238 
fact that the byproduct with m/z 287 starts to decrease at a lower ozone dosage, 4.0 mg 239 
O3 L
-1
, than the E1 byproduct with m/z 285. 240 
The elemental compositions proposed by the Masslynx software for the 241 
experimental accurate masses measured by the QqTOF-MS/MS detector, after applying 242 
basic organic chemical rules to eliminate nonfeasible formulae and possible degradation 243 
scenarios for the parent compounds, were C18H23O3 for m/z 287 and C16H21O4 for m/z 244 
277. However, considering the structure of E2 and that the most probable attack occurs 245 
at the aromatic ring (high electronic densities) there are more than one possible structure 246 
for m/z 287 or, in other words, with mass 288. The structures proposed so far in the 247 
scientific literature for E2 disinfection byproducts with molecular mass 288 have been: 248 
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2-hydroxyestradiol (2OH-E2), identified by both Bila et al. (2007) and Maniero et al. 249 
(2008), monohydroxylated E2 (Irmak et al., 2005), 10e-17b-dihydroxy-1,4-estradieno-250 
3-one (DEO) (Bila et al., 2007) and testosterone (Bila et al., 2007; Maniero et al., 2008) 251 
in ozonation experiments. In experiments performed with other types of oxidation 252 
processes such as, photo-Fenton, photolysis, or TiO2 photocatalysis the compounds 253 
previously identified were: 6-hydroxyestradiol (6OH-E2) (Mazellier et al., 2008; Zhao 254 
et al., 2008), again 2OH-E2 , testosterone (Ohko et al., 2002; Zhao et al., 2008) and 255 
DEO (Mai et al., 2008; Zhao et al., 2008). The E2 byproduct with mass 278 (m/z 277) 256 
has never been reported in the literature. 257 
Trying to elucidate the structure of the byproduct with mass 288 the standards that 258 
were available (2OH-E2, 4OH-E2, and 6OH-E2) were acquired and analyzed. However, 259 
as it can be seen in Figure 3 the retention times of the standards 2OH-E2 (5.69 min) and 260 
4OH-E2 (5.79 min) were very different from the retention time of the E2 byproducts 261 
with MM 288 (4.05 and 4.36 min) detected in our ozonation experiments (16.7 mg O3 262 
L
-1
). On the contrary the retention time of the standard 6OH-E2 (3.99 min) was quite 263 
similar, but when the molecules were fragmented their fragments were totally different 264 
from each other, indicating that 6OH-E2 is not the targeted byproduct. The standard of 265 
estriol (E3), which also has a MM of 288, was tested as well, but the LC-MS data did 266 
not fit either. Apart from these there are other structure possibilities for MM 288, but 267 
these structures do not have their corresponding counterparts for MM 286 when the 268 
same degradation mechanism is applied to the E1 molecule. The compound testosterone 269 
was also disregarded because its formulae (C19H28O2) contains only two oxygens 270 
(instead of three). Thus the byproduct with MM 288 is expected to be the compound 271 
named DEO. DEO was suggested by Ohko et al. in 2002 as byproduct in the mechanism 272 
of degradation of E2 by TiO2 photocatalysis (Ohko et al., 2002) and further confirmed 273 
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by Mai et al. in 2008 in similar oxidative processes by LC-MS/MS analysis (Mai et al., 274 
2008). Furthermore, the fragments observed by Mai et al. (2008) were similar to those 275 
found in the present study.  276 
(Figure 3) 277 
The fragmentation of the E2 and E1 byproducts with m/z 287 and m/z 285, 278 
respectively, is shown in Figure 4. The part marked in the square is virtually identical, 279 
i.e., presents the same fragment ions, in both compounds, whereas the circled part 280 
shows a similar fragmentation pattern but with a difference of two mass units. Based on 281 
these spectra and on previously published works (Bila et al., 2007; Mai et al., 2008; 282 
Ohko et al., 2002;  Zhao et al., 2008) the E2 byproduct with m/z 287 is believed to be 283 
DEO, and the main E1 byproduct with m/z 285 is believed to correspond to a similar 284 
compound but with a ketone group instead of a hydroxyl group in position 17, i.e. to 10-285 
hydroxy-1,4-estradieno-3,17-dione (HEDO). 286 
(Figure 4) 287 
The formation pathway of DEO from E2 has already been suggested by Mai et al. 288 
(2008) and according to it the formation pathway of the above suggested E1 byproduct 289 
would be the same.  290 
It may be worth mentioning that the pH of the samples (measured at the beginning 
291 
and at the end of the experiments) decreased as the formation of the byproducts 
292 
increased (following the loss of H
+
 and the addition of OH in the molecule) and vice 
293 
versa, as it is shown in Supplementary Information - 3 for the byproduct with m/z 285. 
294 
For the E2 and E1 byproducts with m/z 277 and m/z 275, respectively, the pathway 295 
of degradation based on the mechanism of phenol ozonolysis (Komissarov et al., 2006) 296 
is suggested. This pathway is illustrated in Figure 5 for E2. The pathway for E1 would 297 
be similar but maintaining the ketone group that is present in position 17 in the original 298 
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E1 structure. Figure 6 shows the product ion mass spectra and the purported 299 
fragmentation of the byproducts with m/z 277 and m/z 275 that support the proposed 300 
structures. 301 
The finding of these byproducts, not reported previously by other authors, could be 302 
due to the use of different equipments and/or experimental conditions. In the works 303 
performed by Bila et al. (2007) and Maniero et al. (2008) the ozone doses and the initial 304 
concentration of E2 were comparable to those used in the present study but the 305 
identification of byproducts was carried out by GC/MS. In the work conducted by 306 
Irmak et al. (2005) the detection of byproducts was performed by LC-MS/MS but the 307 
conditions of the experiment were very different from ours with higher initial estrogen 308 
concentrations and unclear doses of ozone consumed. Another possible difference could 309 
be the reactive form triggering the process in each work, which in our study, conducted 310 
at pH around 7, would be basically molecular ozone and in other studies OH radicals. 311 
(Figure 5) 312 
(Figure 6) 313 
The ozonation experiments carried out at lower initial concentrations of the 314 
estrogens (100 ng L
-1
) were conducted with the double objective of, first, confirming the 315 
formation of the previously identified main byproducts at concentrations in water closer 316 
to those found in the environment and, secondly, determining the ozone dosage that 317 
would have to be applied to remove them. Figure 7 shows the evolution of the targeted 318 
byproducts during the ozonation experiments. As it can be seen, some byproducts were 319 
formed and reached their maximum concentration at an ozone dosage of approximately 320 
0.5 mg O3 L
-1
, decreasing afterwards. Comparatively, the E2 byproducts, that persisted 321 
until an ozone dosage of 16 mg O3 L
-1
, were more recalcitrant than the E1 byproducts, 322 
that disappeared at a lower ozone dosage of 10 mg O3 L
-1
. 323 
 
 14 
The E2 and E1 byproducts with m/z 287 and m/z 285, respectively, had the same 324 
behavior, being both completely removed (below equipment detection limits) after an 325 
ozone dosage of 4 mg O3 L
-1 
(Figure 7). The E1 byproduct with m/z 275 and the E2 326 
byproduct with m/z 277 remained longer in the solution, until the ozone dosage reached 327 
10 and 16 mg O3 L
-1
, respectively. 328 
(Figure 7) 329 
Several authors that have investigated the estrogenicity of disinfected waters have 330 
observed estrogenic activity after water ozonation (Alum et al., 2004; Huber et al., 331 
2004; Kim et al., 2004; Maniero et al., 2008), indicating the occurrence of byproducts 332 
and that these byproducts are also biologically active even after application of high 333 
ozone dosages. An increase in the concentration of ozone from 0.5 to 10 mg L
-1
 has 334 
been shown to reduce the estrogenicity of the original water by a factor of 200 to 1000 335 
(Huber et al., 2004). This residual estrogenicity, although low, may still be relevant if 336 
we consider that water is just one of many possible routes of exposure to estrogenic 337 
compounds.  338 
4.  Conclusions 339 
E2 and E1 have shown to be efficiently removed from water through ozonation, but 340 
to form each of them two major byproducts. These byproducts with MM 288 and 278, 341 
and 286 and 276, respectively, have been tentatively identified (the last three for the 342 
first time) by means of UPLC-QqTOF-MS/MS. E2 and E1 are believed to follow the 343 
same degradation pathway since their corresponding byproducts, alike them, differ in 344 
two mass units. The total elimination of these byproducts occurred only with high ozone 345 
dosages (10 mg and 16 mg O3 L
-1
 for the E1 and E2 byproducts, respectively).  346 
The ozonation byproducts can pose a risk not only to drinking water consumers but 347 
also to aquatic organisms that can become exposed to them through reclaimed water 348 
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having been subjected to ozonation or when ozone treated wastewater is released into 349 
the environment. Thus, for a proper evaluation of the risk associated to the use of 350 
ozonized water, the ecotoxicity and estrogenicity of the byproducts should be evaluated.  351 
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Figure 1. Degradation of E1 and E2 during ozonation in the experiments carried out 
with an initial concentration of the estrogens in water of 100 μg L-1.  
 
Figure 2. Mass-to-charge (m/z) ratio and retention time of the main byproducts 
identified with different doses of ozone in the degradation of: (A) E1 and (B) E2 with 
an initial concentration of the estrogens in water of 100 μg L-1. 
 
Figure 3. Extracted ion (m/z 287) UPLC-QqTOF-MS chromatograms obtained from the 
analysis of E2 treated with 16.7 mg O3 L
-1
 and from the analysis of standards of 4OH-
E2, 2OH-E2 and 6OH-E2.  
 
Figure 4. Product ion mass spectra obtained from the UPLC-QqTOF-MS/MS analysis 
of (a) an E2 experiment sample (parent ion 287) and (b) an E1 experiment sample 
(parent ion 285), and suggested corresponding structures. Cone voltage, 30 V; CE, 20 
eV.  
 
Figure 5. Proposed pathway for the formation of the E2 byproduct with m/z 277 
observed in the ozonation experiments. 
 
Figure 6. Product ion mass spectra and purported fragmentation of the byproducts with 
m/z 277 (A) and m/z 275 (B) formed during ozonation of E2 and E1, respectively.  
 
Figure 7.  Formation and degradation of the main E2 (A) and E1 (B) byproducts during 
ozonation. Initial concentration of estrogens in water 100 ng L
-1
. 
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